Lv4
496 积分 2024-05-11 加入
An Improved Impact Ratio for Identifying Critical Process Parameters in Pharmaceutical Manufacturing Processes
26天前
已完结
Proposal on How To Conduct a Biopharmaceutical Process Failure Mode and Effect Analysis (FMEA) as a Risk Assessment Tool
1个月前
已完结
Beyond viability: Advancing CHO cell culture process strategies to modulate host cell protein levels
1个月前
已完结
Purification and characterization of a novel chitinase gene from Paecilomyces thermophila expressed in Escherichia coli
1个月前
已完结
Ranking the Susceptibility of Disulfide Bonds in Human IgG1 Antibodies by Reduction, Differential Alkylation, and LC−MS Analysis
1个月前
已完结
Antibody–Drug Conjugates: An Overview of theCMCand Characterization Process
1个月前
已完结
Control of antibody high and low molecular weight species by depth filtration‐based cell culture harvesting
2个月前
已完结
A parallel demonstration of different resins' antibody aggregate removing capability by a case study
3个月前
已完结
A potential downstream platform approach for WuXiBody-based IgG-like bispecific antibodies
3个月前
已完结
Cation exchange frontal chromatography for the removal of monoclonal antibody aggregates
3个月前
已完结
皖公网安备34019202002308
